Synthetic cannabinoids JWH-018 and JWH-073 acted like THC in monkeys but wore off faster
In monkeys trained to recognize THC, synthetic cannabinoids JWH-018 and JWH-073 produced identical subjective effects but lasted only 1-2 hours compared to THC's 4 hours, potentially increasing dependence risk.
Quick Facts
What This Study Found
Researchers tested JWH-018 and JWH-073 (common synthetic cannabinoids in "Spice" and "K2" products) in monkeys trained to discriminate THC from placebo. Both synthetics fully substituted for THC, confirming they produce the same subjective effects through CB1 receptors.
JWH-018 was about 3 times more potent than THC (ED50: 0.013 vs 0.044 mg/kg). JWH-073 was roughly equipotent. Critically, the duration of action was much shorter: JWH-018 lasted about 2 hours and JWH-073 about 1 hour, compared to THC's 4 hours.
Both synthetics also attenuated THC withdrawal in dependent monkeys, confirming pharmacological interchangeability. The shorter duration could promote more frequent dosing, increasing the number of drug-reward pairings and potentially accelerating dependence.
Key Numbers
JWH-018 ED50: 0.013 mg/kg (3x more potent than THC). JWH-073 ED50: 0.058 mg/kg. Duration: JWH-018 ~2 hrs, JWH-073 ~1 hr, THC ~4 hrs. All reversed by CB1 antagonist rimonabant.
How They Did This
Drug discrimination study in rhesus monkeys (n=4) trained to discriminate THC. Additionally tested in monkeys (n=3) trained to discriminate rimonabant (withdrawal) during chronic THC treatment. Dose-response curves, antagonism studies, and duration assessments were conducted.
Why This Research Matters
This study explained why synthetic cannabinoids may be more addictive than natural cannabis: they produce the same high but wear off faster, encouraging more frequent use. More frequent dosing strengthens the habit loop.
The Bigger Picture
This was important pharmacological groundwork for understanding the "Spice/K2" epidemic. The finding that higher potency plus shorter duration equals greater dependence risk had direct public health implications.
What This Study Doesn't Tell Us
Small number of monkeys (3-4). Drug discrimination measures subjective effects, not all aspects of abuse liability. Only two synthetic cannabinoids were tested from hundreds that exist. Laboratory setting does not capture real-world use patterns.
Questions This Raises
- ?Do all synthetic cannabinoids share this short-duration profile?
- ?Would longer-acting synthetics have less abuse liability?
- ?Can these findings inform scheduling decisions for emerging synthetic cannabinoids?
Trust & Context
- Key Stat:
- JWH-018 was 3x more potent than THC but lasted only half as long
- Evidence Grade:
- Primate drug discrimination study with rigorous pharmacological methods. Small sample but highly controlled conditions.
- Study Age:
- Published in 2012. The synthetic cannabinoid landscape has changed dramatically, with hundreds of new compounds since.
- Original Title:
- JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
- Published In:
- The Journal of pharmacology and experimental therapeutics, 340(1), 37-45 (2012)
- Authors:
- Ginsburg, Brett C(3), Schulze, David R(2), Hruba, Lenka(2), McMahon, Lance R
- Database ID:
- RTHC-00561
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Are synthetic cannabinoids more addictive than THC?
This study found JWH-018 was more potent and wore off faster than THC. Shorter duration of action promotes more frequent use, which strengthens drug-seeking habits. Combined with higher potency, this creates a pharmacological profile consistent with greater dependence risk.
Do synthetic cannabinoids work the same way as THC?
Yes, in this study they activated the same CB1 receptors and produced identical subjective effects in monkeys trained to recognize THC. They also relieved THC withdrawal, confirming they act through the same system.
Read More on RethinkTHC
- THC-purity-potency-label-meaning
- dab-concentrate-addiction-withdrawal
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- healthiest-way-to-consume-cannabis
- how-cannabis-products-made-concentrates-edibles
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- sativa-vs-indica-difference-myth
- weed-potency-withdrawal
Cite This Study
https://rethinkthc.com/research/RTHC-00561APA
Ginsburg, Brett C; Schulze, David R; Hruba, Lenka; McMahon, Lance R. (2012). JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.. The Journal of pharmacology and experimental therapeutics, 340(1), 37-45. https://doi.org/10.1124/jpet.111.187757
MLA
Ginsburg, Brett C, et al. "JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.." The Journal of pharmacology and experimental therapeutics, 2012. https://doi.org/10.1124/jpet.111.187757
RethinkTHC
RethinkTHC Research Database. "JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discrimina..." RTHC-00561. Retrieved from https://rethinkthc.com/research/ginsburg-2012-jwh018-and-jwh073-tetrahydrocannabinollike
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.